Algorics’ Chief Commercial Officer Rob Nichols will join Maibritt Haugaard Møller, System Validation Expert at Larix A/S to present, ‘What Does ICH E6 R2 Mean For Risk-Based Monitoring and Clinical Trials?’ to the industry audience at the upcoming OmniComm Systems Innovation Forum taking place from 19-20 October 2017 in Fort Lauderdale, USA.
Presenting at the OmniComm Systems Innovation Forum
Rob and Maibritt will explore how the latest revision to The International Council for Harmonization (ICH) Good Clinical Practice (GCP) E6 R2 guideline affects risk-based monitoring (RBM) strategies, and how risk-based technology and your Clinical Research Organisation (CRO) can help you adhere.
Check out their session to learn more:
- An overview of how ICH moves a risk-based approach from a ‘nice to have’ to a ‘must have’.
- How technology can ensure risks are identified, risk profiles understood and risks controlled in an ICH compliant manner.
- How a Sponsor-CRO relationship works around RBM – what roles are required, what is good practice for new monitoring processes.
- What the future delivery of RBM looks like through a joined up model of eClinical vendors and CRO.
Sponsors of the OmniComm Systems Innovation Forum
Algorics are also delighted to be Gold sponsors for this key annual industry event, bringing together experts and clinical research professionals to explore the evolving requirements of the life sciences industry and how innovation is rising to meet these challenges.
The full agenda is NOW AVAILABLE – to find out more about this key industry event and how to register, check out the event website.
Fort Lauderdale Marriott Harbor Beach Resort & Spa
3030 Holiday Drive
Fort Lauderdale, FL 33316 USA
Toll-Free Room Reservations: 1-800-222-6543